Suppression of lipopolysaccharide-induced microglial activation by a benzothiazole derivative

Molecules and Cells

Volumn 30, Issue 1, 2010, Pages 51-57

  Kim, Eun A ^a,b   Kim, Hanwook ^a   Ahn, Jee Yin ^c   Hahn, Hoh Gyu ^d   Kim, Key Sun ^d   Kim, Tae Ue ^b   Cho, Sung Woo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Korea Institute of Science and Technology   (South Korea)

Author keywords

cytokines; Glia; KHG21834; MAP kinases; neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; BENZOTHIAZOLE DERIVATIVE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KHG 21834; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; INFLAMMATION; MESENCEPHALON; MICROGLIA; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; BENZOTHIAZOLES; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE TYPE II; ONCOGENE PROTEIN V-AKT; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955015433     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0087-y     Document Type: Article

References (68)

1. S.J. Ajizian B.K. English E.A. Meals 1999 Specific inhibitors of p38 and extracellular signal-regulated kinase mitogenactivated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferongamma J. Infect. Dis. 179 939 944 10.1086/314659 1:CAS:528:DyaK1MXitlSls7g%3D 10068590 (Pubitemid 29159340)
2. S.M. Allan P.J. Tyrrell N.J. Rothwell 2005 Interleukin-1β and neuronal injury Nat. Rev. Immunol. 5 629 640 10.1038/nri1664 1:CAS:528:DC%2BD2MXmvVClsLs%3D 16034365 (Pubitemid 41113194)
3. E. Ambrosini F. Aloisi 2004 Chemokines and glial cells: a complex network in the central nervous system Neurochem. Res. 29 1017 1038 10.1023/B:NERE. 0000021246.96864.89 1:CAS:528:DC%2BD2cXisVKrtL8%3D 15139300 (Pubitemid 39011351)
4. P. Barnéoud M. Mazadier J.M. Miquet S. Parmentier P. Dubédat A. Doble A. Boireau 1996 Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat Neuroscience 74 971 983 8895866
5. N.R. Bhat P. Zhang J.C. Lee E.L. Hogan 1998 Extracellular signal-regulated kinase and p38 Subgroups of mitogenactivated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxinstimulated primary glial cultures J. Neurosci. 18 1633 1641 1:CAS:528:DyaK1cXht12jtbo%3D 9464988
6. J.C. Breitner 1996 The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease Annu. Rev. Med. 47 401 411 10.1146/annurev.med.47.1.401 1:CAS:528:DyaK28XitlSntLg%3D 8712791 (Pubitemid 26138900)
7. M. Caivano P. Cohen 2000 Role of MAP kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and interleukin-1β in RAW264 macrophages J. Immunol. 164 3018 3025 1:CAS:528:DC%2BD3cXhvVelu7o%3D 10706690
8. A.B. Carter M.M. Monick G.W. Hunninghake 1999 Both Erk and p38 Kinases are necessary for cytokine gene transcription Am. J. Respir. Cell. Mol. Biol. 20 751 758 1:CAS:528:DyaK1MXisFWksL8%3D 10101008
9. C.C. Chen J.K. Wang 1999 p38 but not p44/42 Mitogenactivated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages Mol. Pharmacol. 55 481 488 1:CAS:528:DyaK1MXhslWjur8%3D 10051531
10. M.M. Choi E.A. Kim H.G. Hahn K.D. Nam S.J. Yang S.Y. Choi T.U. Kim S.W. Cho J.W. Huh 2007 Protective effect of benzothiazole derivative KHG21834 on amyloid betainduced neurotoxicity in PC12 cells and cortical and mesencephalic neurons Toxicology 239 156 166 10.1016/j.tox.2007.07.010 1:CAS:528: DC%2BD2sXpvFGrtrw%3D 17714846 (Pubitemid 47347964)
11. C.K. Combs J.C. Karlo S.C. Kao G.E. Landreth 2001 β-amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis J. Neurosci. 21 1179 1188 1:CAS:528:DC%2BD3MXhtFers7c%3D 11160388
12. J.M. Craft D.M. Watterson S.A. Frautschy L.J. Van Eldik 2004 Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo Neurobiol. Aging 25 1283 1292 10.1016/j.neurobiolaging.2004.01. 006 1:CAS:528:DC%2BD2cXotFCmurg%3D 15465624 (Pubitemid 39299164)
13. V.L. Dawson H.P. Brahmbhatt J.A. Mong T.M. Dawson 1994 Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures Neuropharmacology 33 1425 1430 10.1016/0028-3908(94)90045-0 1:CAS:528:DyaK2cXmvFOqsbo%3D 7532825 (Pubitemid 24353737)
14. D.W. Dickson S.C. Lee L.A. Mattiace S.H. Yen C. Brosnan 1993 Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease Glia 7 75 83 10.1002/glia.440070113 1:STN:280: DyaK3s7jvVOntQ%3D%3D 8423065
15. P. Eikelenboom W.A. Gool 2004 Neuroinflammatory perspectives on the two faces of Alzheimer's disease J. Neural. Transm. 111 281 294 10.1007/s00702-003- 0055-1 1:CAS:528:DC%2BD2cXhsFequ7k%3D 14991455 (Pubitemid 38316606)
16. H.C.A. Emsley C.J. Smith R.F. Georgiou A. Vail S.J. Hopkins N.J. Rothwell P.J. Tyrrell 2005 A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients J. Neurol. Neurosurg. Psychiatry 76 1366 1372 10.1136/jnnp.2004.054882 1:STN:280:DC%2BD2Mvpslyitg%3D%3D 16170078 (Pubitemid 41360973)
17. L.G. Epstein 1998 HIV neuropathogenesis and therapeutic strategies Acta Paediatr. Jpn. 40 107 111 1:STN:280:DyaK1c3kt1equw%3D%3D 9581298
18. S.A. Frautschy F. Yang L. Calderon G.M. Cole 1996 Rodent models of Alzheimer's disease: rat Aβ infusion approaches to amyloid deposits Neurobiol. Aging 17 311 321 10.1016/0197-4580(95)02073-X 1:STN:280: DyaK28zgtleqsA%3D%3D 8744413 (Pubitemid 26167642)
19. H.M. Gao J. Jiang B. Wilson W.Q. Zhang J.S. Hong B. Liu 2002 Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease J. Neurochem. 81 1285 1297 10.1046/j.1471-4159.2002.00928.x 1:CAS:528:DC%2BD38XltVWks7s%3D 12068076 (Pubitemid 34809262)
20. D. Giulian 1999 Microglia and the immune pathology of Alzheimer disease Am. J. Hum. Genet. 65 13 18 10.1086/302477 1:STN:280:DyaK1M3psVGktA%3D%3D 10364511 (Pubitemid 30470443)
21. F. Gonzalez-Scarano G. Baltuch 1999 Microglia as mediators of infammatory and degenerative diseases Annu. Rev. Neurosci. 22 219 240 10.1146/annurev. neuro.22.1.219 1:CAS:528:DyaK1MXhvFemsrY%3D 10202538 (Pubitemid 29144887)
22. V. Heiser S. Engemann W. Brocker I. Dunkel A. Boeddrich S. Waelter E. Nordhoff R. Lurz N. Schugardt S. Rautenberg, et al. 2002 Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay Proc. Natl. Acad. Sci. USA 99 16400 16406 10.1073/pnas.182426599 1:CAS:528:DC%2BD38Xps12htrg%3D 12200548 (Pubitemid 35470985)
23. M.T. Heneka P.A. Loschmann M. Gleichmann M. Weller J.B. Schulz U. Wullner T. Klockgether 1998 Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide J. Neurochem. 71 88 94 10.1046/j.1471-4159.1998.71010088.x 1:CAS:528:DyaK1cXktFams7s%3D 9648854
24. E. Hockly J. Tse A.L. Barker D.L. Moolman J.L. Beunard A.P. Revington K. Holt S. Sunshine H. Moffitt K. Sathasivam, et al. 2006 Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease Neurobiol. Dis. 21 228 236 10.1016/j.nbd.2005.07.007 1:CAS:528:DC%2BD2MXhtlCkt7fJ 16111888 (Pubitemid 41817321)
25. Y. Jin E.Z. Yan Y. Fan Z.H. Zong Z.M. Qi Z. Li 2005 Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus Acta Pharmacol. Sin. 26 943 951 10.1111/j.1745-7254.2005.00158.x 1:CAS:528: DC%2BD2MXoslGksLw%3D 16038626 (Pubitemid 41153214)
26. E.J. Jung D.R. Kim 2008 Apoptotic cell death in TrkAoverexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation Mol. Cells 26 12 17 1:CAS:528:DC%2BD1cXhtVehs7rL 18511888
27. W.G. Kim R.P. Mohney B. Wilson G.H. Jeohn B. Liu J.S. Hong 2000 Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia J. Neurosci. 20 6309 6316 1:CAS:528: DC%2BD3cXlvVGjtbs%3D 10934283
28. H. Kleinert P.M. Schwarz U. Forstermann 2003 Regulation of the expression of inducible nitric oxide synthase Biol. Chem. 384 1343 1364 10.1515/BC.2003.152 1:CAS:528:DC%2BD3sXpsFClsrk%3D 14669979 (Pubitemid 37508640)
29. W.E. Klunk Y. Wang G. Huang M.L. Debnath D.P. Holt L. Shao R.L. Hamilton M.D. Ikonomovic S.T. DeKosky C.A. Mathis 2003 The binding of 2-(4'-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component J. Neurosci. 23 2086 2092 1:CAS:528:DC%2BD3sXlsV2qsb8%3D 12657667
30. A. Knethen F. Brockhaus I. Kleiter B. Brune 1999 NOevoked macrophage apoptosis is attenuated by cAMP-induced gene expression Mol. Med. 5 672 684
31. M. Koistinaho J. Koistinaho 2002 Role of p38 and p44/42 mitogenactivated protein kinases in microglia Glia 40 175 183 10.1002/glia.10151 12379905 (Pubitemid 35337375)
32. R. Korhonen A. Lahti H. Kankaanranta E. Molanen 2005 Nitric oxide production and signalling in inflammation Curr. Drug Targets Inflamm. Allergy 4 471 479 10.2174/1568010054526359 1:CAS:528:DC%2BD2MXmvV2iu78%3D 16101524 (Pubitemid 41052412)
33. S.E. Laursen J.K. Belknap 1986 Intracerebroventricular injections in mice. Some methodological refinements J. Pharmacol. Methods 16 355 357 10.1016/0160-5402(86)90038-0 1:CAS:528:DyaL2sXktlehtg%3D%3D 3784576 (Pubitemid 17189961)
34. Y. Liu L. Qin B.C. Wilson L. An J.S. Hong B. Liu 2002 Inhibition by Naloxone stereoisomers of β-amyloid peptide (1-42) induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons J. Pharmacol. Exp. Ther. 302 1212 1219 10.1124/jpet.102.035956 1:CAS:528:DC%2BD38XmsF2ht7Y%3D 12183682 (Pubitemid 34920245)
35. L.V. Madrid C.Y. Wang D.C. Guttridge A.J. Schottelius Jr. A.S. Baldwin M.W. Mayo 2000 Akt suppresses apoptosis by stimulating the transactivation potential of the Rel A/p65 subunit of NF-κB Mol. Cell. Biol. 20 1626 1638 10.1128/MCB.20.5.1626-1638.2000 1:CAS:528:DC%2BD3cXhtF2nt74%3D 10669740 (Pubitemid 30100182)
36. C.A. Mathis B.J. Bacskai S.T. Kajdasz M.E. Mclellan M.P. Frosch B.T. Hyman D.P. Holt Y. Wang G.-F. Huang M.L. Debnath, et al. 2002 A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain Bioorg. Med. Chem. Lett. 12 295 298 10.1016/S0960-894X(01) 00734-X 1:CAS:528:DC%2BD38XpslKmtQ%3D%3D 11814781 (Pubitemid 34113887)
37. T. Matsuguchi A. Masuda K. Sugimoto Y. Nagai Y. Yoshikai 2003 JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation EMBO J. 22 4455 4464 10.1093/emboj/cdg438 1:CAS:528:DC%2BD3sXmvVWrsrk%3D 12941697 (Pubitemid 37087199)
38. M.K. Matyszak 1998 Inflammation in the CNS: balance between immunological privilege and immune responses Prog. Neurobiol. 56 19 35 10.1016/S0301-0082(98) 00014-8 1:CAS:528:DyaK1cXlsVOru7w%3D 9723129 (Pubitemid 28351160)
39. D.R. McDonald K.R. Brunden G.E. Landreth 1997 Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia J. Neurosci. 17 2284 2294 1:CAS:528:DyaK2sXitV2ju7c%3D 9065490
40. P.L. McGeer E.G. McGeer 1995 The inflammatory response system of brain: Implications for therapy of Alzeimer and other neurodegenerative diseases Brain Res. Brain Res. Rev. 21 195 218 10.1016/0165-0173(95)00011-9 1:STN:280:DyaK2s%2FitVaqsg%3D%3D 8866675 (Pubitemid 26061873)
41. P.L. McGeer S. Itagaki B.E. Boyes E.G. McGeer 1988 Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains Neurology 38 1285 1291 1:STN:280:DyaL1c3ovVKkuw%3D%3D 3399080
42. L. Meda M.A. Cassatella G.I. Szendrei L. Jr. Otvos P. Baron M. Villalba D. Ferrari F. Rossi 1995 Activation of microglial cells by beta-amyloid protein and interferon-gamma Nature 374 647 650 10.1038/374647a0 1:CAS:528: DyaK2MXltVOhsLs%3D 7715705
43. J.E. Merrill Y. Koyanagi J. Zack L. Thomas F. Martin I.S. Chen 1992 Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1 J. Virol. 66 2217 2225 1:CAS:528: DyaK38XhvFansrg%3D 1548758
44. L. Minghetti G. Levi 1998 Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide Prog. Neurobiol. 54 99 125 10.1016/S0301-0082(97)00052-X 1:CAS:528:DyaK1cXmsl2ktg%3D%3D 9460796 (Pubitemid 28049822)
45. A.H. Moore M.K. O'Banion 2002 Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease Adv. Drug Deliv. Rev. 54 1627 1656 10.1016/S0169-409X(02)00162-X 1:CAS:528:DC%2BD38XovFemtLo%3D 12453679 (Pubitemid 35350856)
46. M. Nikodemova I.D. Duncan J.J. Watters 2006 Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I Ba degradation in a κ stimulus-specific manner in microglia J. Neurochem. 96 314 323 10.1111/j.1471-4159.2005.03520.x 1:CAS:528:DC%2BD28XntVSjsw%3D%3D 16336636
47. T.J. O'Dell E.R. Kandel S.G. Grant 1991 Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors Nature 353 558 560 10.1038/353558a0 1656271
48. L. Pollak T. Hanoch M.J. Rabey R. Seger 2005 Infectious inflammation of the CNS involves activation of mitogen-activated protein kinase and Akt proteins in CSF in humans Neurol. Sci. 26 324 329 10.1007/s10072-005-0504-8 1:STN:280:DC%2BD28%2Fgt1WitQ%3D%3D 16388366 (Pubitemid 43091341)
49. E. Puré L. Tardelli 1992 Tyrosine phosphorylation is required for ligand-induced internalization of the antigen receptor in B lymphocytes Proc. Natl. Acad. Sci. USA 89 114 117 10.1073/pnas.89.1.114 1370346
50. L. Qin Y. Liu C. Cooper B. Liu B. Wilson J.S. Hong 2002 Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species J. Neurochem. 83 973 983 10.1046/j.1471-4159.2002.01210.x 1:CAS:528:DC%2BD38XovFOisbs%3D 12421370 (Pubitemid 35316048)
51. C.S. Raine 1994 Multiple sclerosis: immune system molecule expression in the central nervous system J. Neuropathol. Exp. Neurol. 53 328 337 10.1097/00005072-199407000-00002 1:STN:280:DyaK2c3ptlSguw%3D%3D 8021705
52. H.R. Ranaivo J.M. Craft W. Hu L. Guo L.K. Wing L.J.V. Eldik D.M. Watterson 2006 Glia as a therapeutic target: Selective suppression of human amyloid-β-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration J. Neurosci. 26 662 670 10.1523/JNEUROSCI.4652-05. 2006 1:CAS:528:DC%2BD28XosFWquw%3D%3D (Pubitemid 43237131)
53. G. Sebastiani C. Morisette C. Lagace M. Boule M.J. Quollette R.W. McLaughin D. Lacombe F. Cervais P. Trembley 2006 The cAMP-specific phosphodiesterase 4B mediates Aβ-induced microglial activation Neurobiol. Aging 27 691 701 10.1016/j.neurobiolaging.2005.03.024 1:CAS:528: DC%2BD28Xjs1Wns7c%3D 15993984
54. K. Shirakabe K. Yamaguchi H. Shibuya K. Irie S. Matsuda T. Moriguchi Y. Gotoh K. Matsumoto E. Nishida 1997 TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase J. Biol. Chem. 272 8141 8144 10.1074/jbc.272.13.8141 1:CAS:528:DyaK2sXitF2ju7k%3D 9079627 (Pubitemid 27147762)
55. D.H. Small S.S. Mok J.C. Bornstein 2001 Alzheimer's disease and Aβ toxicity: from top to bottom Nat. Rev. Neurosci. 2 595 598 10.1038/35086072 1:CAS:528:DC%2BD3MXmtVaqur4%3D 11484003 (Pubitemid 33679833)
56. T.M. Tikka B.L. Fiebich G. Goldsteins R. Keinanen J.E. Koistinaho 2001 Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia J. Neurosci. 21 2580 2588 1:CAS:528:DC%2BD3MXjtVWkurk%3D 11306611
57. R. Treisman 1996 Regulation of transcription by MAP kinase cascades Curr. Opin. Cell Biol. 8 205 215 10.1016/S0955-0674(96)80067-6 1:CAS:528: DyaK28XitVWktbk%3D 8791420 (Pubitemid 26109094)
58. F. Vilhardt 2005 Microglia: phagocyte and glia cell Int. J. Biochem. Cell Biol. 37 17 21 10.1016/j.biocel.2004.06.010 1:CAS:528:DC%2BD2cXnslKgsrY%3D 15381143 (Pubitemid 39286017)
59. Y.T. Wang M.W. Salter 1994 Regulation of NMDA receptors by tyrosine kinases and phosphatases Nature 369 233 235 10.1038/369233a0 1:CAS:528:DyaK2cXktVWlu7k%3D 7514272 (Pubitemid 24154800)
60. C.X. Wang A. Schuaib 2002 Involvement of inflammatory cytokines in central nervous system injury Prog. Neurobiol. 67 161 172 10.1016/S0301-0082(02) 00010-2 1:CAS:528:DC%2BD38Xlt1OitLY%3D 12126659 (Pubitemid 34786168)
61. M.J. Wang W.W. Lin H.L. Chen Y.H. Chang H.C. Ou J.S. Kuo J.S. Hong K.C. Jeng 2002 Silymarin protects dopaminergic neurons against lipopolysaccharide- induced neurotoxicity by inhibiting microglia activation Eur. J. Neurosci. 16 2103 2112 10.1046/j.1460-9568.2002.02290.x 12473078 (Pubitemid 36001990)
62. K. Watson G.H. Fan 2005 Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogenactivated protein kinase and phosphatidylinositol 3-kinase signaling pathways Mol. Pharmacol. 67 757 765 10.1124/mol.104.004812 1:CAS:528:DC%2BD2MXitlaqsLo%3D 15608143 (Pubitemid 40365323)
63. J.A. White A.M. Manelli K.H. Holmberg L.J. Van Eldik M.J. Ladu 2005 Differential effects of oligomeric and fibrillar amyloid-beta1-42 on astrocyte-mediated inflammation Neurobiol. Dis. 18 459 465 10.1016/j.nbd.2004. 12.013 1:CAS:528:DC%2BD2MXhvFygu7Y%3D 15755672 (Pubitemid 40332705)
64. H. Wilms L. Zecca P. Rosenstiel J. Sievers G. Deuschl R. Lucius 2007 Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Curr. Pharm. Des. 13 1925 1928 10.2174/138161207780858429 1:CAS:528:DC%2BD2sXnsVWqsbs%3D 17584117 (Pubitemid 47017994)
65. J. Wood P. Zinsmeister 1991 Tyrosine phosphorylation systems in Alzheimer's disease pathology Neurosci. Lett. 121 12 16 10.1016/0304-3940(91) 90637-9 1:CAS:528:DyaK3MXisVGgu78%3D 1708471
66. M.-S. Woo J.-S. Park I.-Y. Choi W.-K. Kim H.-S. Kim 2008 Inhibition of MMP-3 or MMP-9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia J. Neurochem. 106 770 780 10.1111/j.1471-4159.2008.05430.x 1:CAS:528:DC%2BD1cXovFWgtbo%3D 18419763
67. X. Wu G.A. Zimmerman S.M. Prescott D.M. Stafforini 2004 The p38 MAPK pathway mediates transcriptional activation of the plasma platelet-activating factor acetylhydrolase gene in macrophages stimulated with lipopolysaccharide J. Biol. Chem. 279 36158 36165 10.1074/jbc.M402454200 1:CAS:528: DC%2BD2cXmsl2huro%3D 15215249 (Pubitemid 39100624)
68. Y. Zhou E.A. Ling S.T. Dheen 2007 Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia J. Neurochem. 102 667 678 10.1111/j.1471-4159.2007.04535.x 1:CAS:528:DC%2BD2sXovVyju70%3D 17403137 (Pubitemid 47057277)